Citation Information :
John N, Lancy J, Girija K. Molecular characterisation of extended spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from urinary specimens. 2016; 18 (1):55-59.
Extended spectrum beta lactamase (ESBL) production is a major resistance mechanism of Gram-negative bacteria. Phenotypic tests for ESBL detection only confirm whether an ESBL is produced or not, but it cannot detect the ESBL subtype. There are various genotypes of ESBLs. Of these, the most common are the TEM, SHV and CTX-M types. Fifty phenotypically ESBL-producing Escherichia coli and Klebsiella pneumoniae urinary isolates were subjected to polymerase chain reaction to look for the presence of blaTEM, blaSHVand blaCTX-Mgenes. Forty-one isolates were positive for TEM gene, eleven isolates were positive for SHV gene and 10 isolates were positive for CTX-M gene. Both TEM and SHV genes were present in six isolates. Two isolates showed the simultaneous presence of CTX-M and TEM genes. All the three genes were present in two isolates.
Matha D, Manoharan A, Vasanthan G. Epidemiology and implications of ESBL. Crit Care Update 2009;14:152-62.
Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative Bacill in the Asia-Pacific region: Data from the study for monitoring antimicrobial resistance trends (SMART) program, 2007. Antimicrob Agents Chemother 2009;53:3280-4.
Gupta V. An update on newer beta-lactamases. Indian J Med Res 2007;126:417-27.
Borg MA, Scicluna E, de Kraker M, van de Sande-Bruinsma N, Tiemersma E, Gür D, Antibiotic resistance in the Southeastern Mediterranean – Preliminary results from the ARMed project. Euro Surveill 2006;11:164-7.
Pushpa D, Arora U, Kaur K. Prevalence of extended spectrum beta lactamase producing gram negative uropathogens in a tertiary care hospital. J Acad Clin Microbiologists 2009;11:56-65.
Babypadmin S, Appalaraju B. Extended spectrum-lactamases in urinary isolates of and – Prevalence and susceptibility pattern in a tertiary care hospital. Indian J Med Microbiol 2004;22:172-4.
Supriya S. Evaluation of ESBL in urinary isolates. Indian J Med Res 2004;22:172-4.
Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement. CLSI M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute; 2010.
Hawkey PM. Prevalence and clonality of extended-spectrum beta-lactamases in Asia. Clin Microbiol Infect 2008;14 Suppl 1:159-65.
Sharma J, Ray P, Sharma M, Ghosh S. Comparison of isoelectric focusing and polymerase chain reaction for the detection of ß-lactamases. Indian J Med Microbiol 2010;28:376-9.
Jemima SA, Verghese S. Molecular characterization of nosocomial CTX-M type beta-lactamase producing Enterobacteriaceae from a tertiary care hospital in South India. Indian J Med Microbiol 2008;26:365-8.
Sekar B, Arunagir K, Menaka K, Lalitha P, Aparna V, Oommen PK. Detection and Characterization of bla-CTX-M Gene by PCR-RFLP Analysis Among Third Generation Cephalosporin Resistant Gram-negative Isolates. XXX National Congress of Indian Association of Medical Microbiologists. Microcon; 2006. p. 27.
Manoharan A, Premalatha K, Chatterjee S, Matha D; SARI Study Group. Correlation of TEM, SHV and CTX-M extended-spectrum beta lactamases among Enterobacteriaceae with their antimicrobial susceptibility. Indian J Med Microbiol 2011;29:161-4.
